The ImClone Story: A Hyped Drug, a Tainted Icon
The ImClone Story: A Hyped Drug, a Tainted Icon It was, in retrospect, a festival of hype emblematic of the boom years, when technology stocks seemed to have nowhere to go but up.
The ImClone Story: A Hyped Drug, a Tainted Icon It was, in retrospect, a festival of hype emblematic of the boom years, when technology stocks seemed to have nowhere to go but up.
Five Hurdles for Biotech The science is hot and the stocks are up. Here’s what’s needed to deliver on the promise.
Get new actionable insights and updates from BiotechBlog